A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease - The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial


Pepine C., Handberg E., Cooper-DeHoff R., Marks R. G. , Kowey P., Meserelli F. H. , et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, cilt.290, ss.2805-2816, 2003 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 290 Konu: 21
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1001/jama.290.21.2805
  • Dergi Adı: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
  • Sayfa Sayısı: ss.2805-2816

Özet

Context Despite evidence of efficacy of anti hypertensive agents in treating hypertensive patients, safety and efficacy of anti hypertensive agents for coronary artery disease (CAD) have been discerned only from subgroup analyses in large trials.